SHARE BASED COMPENSATION (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| SCHEDULE OF EXERCISE PRICES AND REMAINING CONTRACTUAL LIVES OF OUTSTANDING OPTIONS |
The
following is information regarding exercise prices and remaining contractual lives of outstanding options at December 31, 2025:
SCHEDULE OF EXERCISE PRICES AND REMAINING CONTRACTUAL LIVES OF OUTSTANDING OPTIONS
| December 31, 2025 | |
| Outstanding | | |
Exercisable | |
Number of
options
outstanding | | |
Exercise
price
range
(USD) | | |
Weighted
average
remaining
contractual life | | |
Number of
options
Exercisable | | |
Exercise
price
range
(USD) | | |
Weighted
average
remaining
contractual life | |
| | 90,750 | | |
| 1.98 | | |
| 8.72 | | |
| 90,750 | | |
| 1.98 | | |
| 8.72 | |
| | 12,000 | | |
| 2.86 | | |
| 8.97 | | |
| 3,000 | | |
| 2.86 | | |
| 8.97 | |
| | 4,372 | | |
| 3.79 | | |
| 7.59 | | |
| 4,372 | | |
| 3.79 | | |
| 7.59 | |
| | 1,311 | | |
| 4.98 | | |
| 7.17 | | |
| 902 | | |
| 4.98 | | |
| 7.17 | |
| | 9,617 | | |
| 5.45 | | |
| 6.98 | | |
| 7,133 | | |
| 5.45 | | |
| 6.98 | |
| | 20,109 | | |
| 6.76 | | |
| 6.52 | | |
| 16,340 | | |
| 6.76 | | |
| 6.52 | |
| | 65,168 | | |
| 7.57 | | |
| 2.00 | | |
| 65,168 | | |
| 7.57 | | |
| 2.00 | |
| | 224,808 | | |
| 7.82 | | |
| 4.82 | | |
| 224,808 | | |
| 7.82 | | |
| 4.82 | |
| | 26,230 | | |
| 8.39 | | |
| 6.84 | | |
| 19,673 | | |
| 8.39 | | |
| 6.84 | |
| | 30,091 | | |
| 8.96 | | |
| 7.30 | | |
| 30,091 | | |
| 8.96 | | |
| 7.30 | |
| | 30,092 | | |
| 10.29 | | |
| 7.30 | | |
| 30,092 | | |
| 10.29 | | |
| 7.30 | |
| | 30,092 | | |
| 13.37 | | |
| 7.30 | | |
| 15,046 | | |
| 13.37 | | |
| 7.30 | |
| | 6,120 | | |
| 20.59 | | |
| 5.84 | | |
| 6,120 | | |
| 20.59 | | |
| 5.84 | |
| | 550,760 | | |
| 7.27 | | |
| 5.86 | | |
| 513,495 | | |
| 7.17 | | |
| 5.74 | |
|
| SCHEDULE OF RESTRICTED STOCK UNIT ACTIVITY |
The
following table summarizes the RSUs activity under the 2015 Plan as of December 31, 2025:
SCHEDULE
OF RESTRICTED STOCK UNIT ACTIVITY
| | |
units | | |
Weighted average
grant date fair value | |
| Outstanding at beginning of year | |
| - | | |
| - | |
| Granted | |
| 24,566,602 | | |
| 1.85 | |
| Vested (*) | |
| (14,400 | ) | |
| 1.99 | |
| Forfeited | |
| - | | |
| - | |
| Outstanding at end of year | |
| 24,566,602 | | |
| 1.85 | |
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
As
of December 31, 2025, there was unrecognized compensation cost related to unvested equity classified RSUs of $38,809 thousand which is
expected to be recognized as an expense on a straight-line basis over a weighted-average remaining vesting period of 3.6 years.
| (*) | | The vested RSUs
as of December 31, 2025, were issued in 2026. |
|
| SCHEDULE OF CHANGES IN FAIR VALUE OF OPTIONS |
The
table below sets forth a summary of changes in the fair value of the options for periods through December 31, 2024:
SCHEDULE
OF CHANGES IN FAIR VALUE OF OPTIONS
| | |
Number of
options
measured at fair
value | | |
Fair value (U.S.
Dollars in
thousands) | |
| Balance at December 31, 2022 | |
| 440,045 | | |
| 996 | |
| Effect of change in exchange rate | |
| | | |
| (30 | ) |
| Changes in fair value | |
| - | | |
| (734 | ) |
| Balance at December 31, 2023 | |
| 405,714 | | |
| 232 | |
| Effect of change in exchange rate | |
| | | |
| (4 | ) |
| Changes in fair value | |
| - | | |
| 74 | |
| Reclassification of liability classified share-based compensation awards to equity | |
| (401,794 | ) | |
| (302 | ) |
| Balance at December 31, 2024 | |
| - | | |
| - | |
|
| SCHEDULE OF EXPENSE(INCOME) RECOGNIZED IN CONSOLIDATED FINANCIAL STATEMENTS |
SCHEDULE
OF EXPENSE(INCOME) RECOGNIZED IN CONSOLIDATED FINANCIAL STATEMENTS
| | |
Year ended December 31 | |
| | |
2025 | | |
2024 | |
| | |
| Equity
classified
awards | | |
| Liability
classified
awards | | |
| Total
expense | | |
| Equity
classified
awards | | |
| Liability
classified
awards | | |
| Total
expense | |
| Research and development expenses (income) | |
| (18 | ) | |
| - | | |
| (18 | ) | |
| 98 | | |
| 42 | | |
| 140 | |
| Sales and marketing expenses (income) | |
| (35 | ) | |
| - | | |
| (35 | ) | |
| 74 | | |
| 20 | | |
| 94 | |
| General and Administrative expenses (income) | |
| 6,754 | | |
| - | | |
| 6,754 | | |
| 122 | | |
| 13 | | |
| 135 | |
| | |
| 6,701 | | |
| - | | |
| 6,701 | | |
| 294 | | |
| 75 | | |
| 369 | |
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
| | |
Year ended December 31 | |
| | |
2023 | |
| | |
| Equity
classified
awards | | |
| Liability
classified
awards | | |
| Total
expense | |
| Research and development expenses (income) | |
| 98 | | |
| (440 | ) | |
| (342 | ) |
| Sales and marketing expenses (income) | |
| 111 | | |
| (171 | ) | |
| (60 | ) |
| General and Administrative expenses (income) | |
| 294 | | |
| (111 | ) | |
| 183 | |
| | |
| 503 | | |
| (722 | ) | |
| (219 | ) |
|
| Equity Classified Awards [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| SCHEDULE OF FAIR VALUE ASSUMPTIONS |
SCHEDULE
OF FAIR VALUE ASSUMPTIONS
| | |
2025 | | |
2024 | | |
2023 | |
| Dividend yield | |
| 0% | | |
| 0% | | |
| 0% | |
| Expected volatility | |
| 74%-85% | | |
| 74%-97% | | |
| 74%-76% | |
| Risk-free interest rate | |
| 3.3%-3.9% | | |
| 3.3%-5.8% | | |
| 3.3%-3.9% | |
| Expected term (years) | |
| 2-3 years | | |
| 2-7 years | | |
| 4-7 years | |
| Exercise price (USD) | |
| 1.98-2.86 | | |
| 1.98-18.01 | | |
| 3.32-11.78 | |
|
| SCHEDULE OF STOCK OPTIONS ACTIVITY |
The
following is summary information of equity classified options in 2025:
SCHEDULE
OF STOCK OPTIONS ACTIVITY
| | |
Year ended December 31, 2025 | |
| | |
| | |
Weighted
average
exercise
price | | |
Weighted
average
remaining
contractual
life | | |
Aggregate
Intrinsic | |
| | |
Number | | |
USD | | |
years | | |
Value | |
| Outstanding at beginning of year | |
| 979,184 | | |
| 6.55 | | |
| 7.5 | | |
| - | |
| Granted | |
| 19,500 | | |
| 2.82 | | |
| 8.99 | | |
| - | |
| Forfeited | |
| (447,924 | ) | |
| 6.26 | | |
| 7.28 | | |
| - | |
| Outstanding at end of year | |
| 550,760 | | |
| 7.27 | | |
| 5.86 | | |
| - | |
| Exercisable at end of year | |
| 513,495 | | |
| 7.17 | | |
| 5.74 | | |
| - | |
|
| Liability Classified Awards [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| SCHEDULE OF FAIR VALUE ASSUMPTIONS |
The
following table summarizes assumptions used as of December 31, 2025, 2024 and 2023:
SCHEDULE
OF FAIR VALUE ASSUMPTIONS
| | |
2025 | | |
2024 | | |
2023 | |
| Expected dividend | |
| - | | |
| - | | |
| 0 | % |
| Expected volatility | |
| - | | |
| - | | |
| 81.2%-90.9% | |
| Risk-free interest rate | |
| - | | |
| - | | |
| 4.97%-5.35% | |
| Expected life (years) | |
| - | | |
| - | | |
| 2-4 years | |
| Exercise price (USD) | |
| - | | |
| - | | |
| 4.57-15.67 | |
|